[1]温 鑫,邓 春.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效评价[J].医学信息,2023,36(06):147-149,153.[doi:10.3969/j.issn.1006-1959.2023.06.032]
　WEN Xin,DENG Chun.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Journal of Medical Information,2023,36(06):147-149,153.[doi:10.3969/j.issn.1006-1959.2023.06.032]
点击复制

盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效评价()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年06期
页码:
147-149,153
栏目:
论著
出版日期:
2023-03-15

文章信息/Info

Title:
Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children
文章编号:
1006-1959（2023）06-0147-04
作者:
温 鑫; 邓 春
（重庆医科大学附属永川医院儿科，重庆 402160）
Author(s):
WEN Xin; DENG Chun
(Department of Pediatrics,Yongchuan Hospital,Affiliated to Chongqing Medical University,Chongqing 402160,China)
关键词:
盐酸氨溴索; 阿奇霉素; 儿童; 肺炎支原体肺炎
Keywords:
Ambroxol hydrochloride; Azithromycin; Children; Mycoplasma pneumoniae pneumonia
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2023.06.032
文献标志码:
A
摘要:
目的 研究盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效。方法 选取2019年1月-2021年12月在我院诊治的402例儿童肺炎支原体肺炎患儿为研究对象，采用随机数字表法分为对照组和观察组，各201例。对照组采用阿奇霉素治疗，观察组在对照组基础上联合盐酸氨溴索治疗。比较两组临床症状消失时间、治疗总有效率、肺功能指标[最大呼气量（FEV1）、用力肺活量（FVC）、每分钟最大通气量（MVV）、用力呼气量占用力肺活量比值（FEV1/FVC）]、炎症因子（白细胞、中性粒细胞、超敏C反应蛋白）水平以及临床不良反应发生情况。结果 观察组发热、咳嗽、肺部湿啰音消失时间均短于对照组（P＜0.05）；观察组治疗总有效率为96.02%，高于对照组的87.06%（P＜0.05）；两组治疗后FEV1、FVC、MVV、FEV1/FVC均高于治疗前，且观察组高于对照组（P＜0.05）；两组治疗后白细胞、中性粒细胞、超敏C反应蛋白均低于治疗前，且观察组低于对照组（P＜0.05）；观察组不良反应发生率为3.98%，与对照组的4.48%比较，差异无统计学意义（P＞0.05）。结论 盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎具有显著的疗效，可提高治疗总有效率，降低炎症因子水平，改善肺功能指标，促进临床症状消失，且不良反应少，是一种有效的联合用药治疗方案。
Abstract:
Objective To study the efficacy of ambroxol hydrochloride combined with azithromycin in the treatment of mycoplasma pneumoniae pneumonia in children.Methods A total of 402 children with mycoplasma pneumoniae pneumonia diagnosed and treated in our hospital from January 2019 to December 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 201 cases in each group. The control group was treated with azithromycin, and the observation group was treated with ambroxol hydrochloride on the basis of the control group. The disappearance time of clinical symptoms, total effective rate of treatment, pulmonary function indexes [maximum expiratory volume (FEV1), forced vital capacity (FVC), maximum ventilation volume per minute (MVV), ratio of forced expiratory volume to forced vital capacity (FEV1/FVC)], inflammatory factors (white blood cells, neutrophils, hypersensitive C-reactive protein) levels and clinical adverse reactions were compared between the two groups.Results The disappearance time of fever, cough and lung moist rale in the observation group was shorter than that in the control group (P<0.05). The total effective rate of treatment in the observation group was 96.02%, which was higher than 87.06% in the control group (P<0.05). After treatment, FEV1, FVC, MVV and FEV1/FVC in the two groups were higher than those before treatment, and those in the observation group were higher than the control group (P<0.05). After treatment, the white blood cells, neutrophils and high-sensitivity C-reactive protein in the two groups were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The incidence of adverse reactions in the observation group was 3.98%, which was compared with 4.48% in the control group, and the difference was not statistically significant (P>0.05).Conclusion Ambroxol hydrochloride combined with azithromycin has a significant effect in the treatment of mycoplasma pneumoniae pneumonia in children, which can improve the total effective rate of treatment, reduce the level of inflammatory factors, improve lung function indicators, promote the disappearance of clinical symptoms, and has fewer adverse reactions. It is an effective combination therapy.

参考文献/References:

[1]黄玉玲.甲基泼尼松龙辅助阿奇霉素对儿童支原体肺炎急性发作的疗效研究[J].河北医药,2016,38(19):2905-2907.[2]Shan LS,Liu X,Kang XY,et al.Effects of methylprednisolo ne or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory mycoplasma pneumon iae pneumonia in children[J].World Pediatr,2017,13(4):321-327.[3]白秀堂.阿奇霉素联合头孢呋辛钠加氨溴索治疗儿童肺炎支原体肺炎临床观察[J].中国药物与临床,2017,17(11):1676-1678.[4]中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2017年版)[J].中华实用儿科临床杂志,2017,30(17):1304-1308.[5]毛国辉.阿奇霉素联合布地奈德混悬液与沙丁胺醇雾化吸入治疗小儿肺炎支原体肺炎疗效与安全性评价[J].蚌埠医学院学报,2017,42(8):1100-1102.[6]张建梅,周金芳,王敏,等.阿奇霉素、孟鲁司特钠联合普米克令舒治疗对支原体肺炎儿童炎症程度、肺功能的影响[J].海南医学院学报,2016,22(18):2171-2173,2177.[7]蔡惠东,潘剑蓉.阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的疗效评价[J].检验医学与临床,2017,14(17):2590-2592.[8]滕丽荣,李小村,路兴志,等.肺炎支原体肺炎后反复呼吸道感染儿童的免疫功能及临床意义[J].中国妇幼保健,2017,32(22):5613-5615.[9]于春琳,赵德育.肺炎支原体肺炎免疫功能与其病情的相关性[J].江苏医药,2017,43(19):1388-1390.[10]Lee H,Yun KW,Lee HJ,et al.Antimicrobial therapy of mac- rolide-resistant Mycoplasma pneumonia pneumonia in children [J].Expert Rev Anti Infect Ther,2018,16(1):23-34.[11]刘金,闫虹,陈小庚,等.槐杞黄颗粒对重型肺炎支原体肺炎患儿免疫功能的影响[J].中国当代儿科杂志,2017,19(7):759-762.[12]赵爱利.吉他霉素治疗小儿肺炎支原体肺炎的疗效及对血清相关炎症细胞因子的影响[J].中国妇幼保健,2017,32(19):4713-4716.[13]黄彩虹,闫凡,白进.阿奇霉素与羚贝止咳糖浆联合治疗小儿肺炎支原体肺炎的安全性与有效性[J].儿科药学杂志,2017,23(8):21-23.[14]林洁,骆林胜,黄鹏,等.肺炎支原体感染与小儿咳嗽变异性哮喘的关系及大环内酯类药物治疗的效果分析[J].中华医院感染学杂志,2016,26(12):2843-2845.[15]柴巧利.阿奇霉素与甘草锌联合治疗对支原体肺炎患儿炎症反应程度及免疫应答功能的影响[J].海南医学院学报,2017,23(14):1938-1940.[16]薄红晓.盐酸氨溴索联合阿奇霉素序贯疗法对支原体肺炎患儿免疫功能及心肌酶谱的影响[J].山西医药杂志,2020,49(4):440-442.[17]黎炳祥,方文,汤文秀.盐酸氨溴索联合阿奇霉素治疗小儿支原体肺炎疗效及对肺功能的影响[J].黑龙江医药,2020,33(2):318-320.[18]周琳,石磊,石焱.阿奇霉素治疗儿童肺炎支原体肺炎疗效观察[J].临床军医杂志,2018,46(6):688-690.[19]田恬,陈晨,赵文静,等.盐酸氨溴索治疗小儿肺炎支原体肺炎的疗效及安全性研究[J].湖南师范大学学报,2018,15(5):132-134.[20]罗学虎,唐建军,余芳蓉,等.氨溴索辅助阿奇霉素治疗对儿童肺炎支原体肺炎患儿血清IFN-7、MCP-4、IL-6水平及免疫功能的影响[J].标记免疫分析与临床,2019,26(2):250-252.

相似文献/References:

[1]赵俊芝,赵永强,梁 曼.甲泼尼龙联合阿奇霉素治疗难治性支原体肺炎患儿的 临床效果分析[J].医学信息,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
　ZHAO Jun-zhi,ZHAO Yong-qiang,LIANG Man.Analysis of the Clinical Effect of Methylprednisolone Combined with Azithromycin in Treatment of Children with Refractory Mycoplasma Pneumonia[J].Journal of Medical Information,2018,31(06):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
[2]许雪花,刘华之,张凤英,等.盐酸氨溴索氧气驱动雾化吸入在甲状腺术后咳痰困难的 疗效观察[J].医学信息,2018,31(11):135.[doi:10.3969/j.issn.1006-1959.2018.11.043]
　XU Xue-hua,LIU Hua-zhi,ZHANG Feng-ying,et al.Effect of Oxygen Atomization Inhalation of Ambroxol Hydrochloride on Postoperative Difficulty of Expectoration after Thyroidectomy[J].Journal of Medical Information,2018,31(06):135.[doi:10.3969/j.issn.1006-1959.2018.11.043]
[3]李安辉,邹 庆,李沛云,等.盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎的效果分析[J].医学信息,2019,32(10):151.[doi:10.3969/j.issn.1006-1959.2019.10.050]
　LI An-hui,ZOU Qing,LI Pei-yun,et al.Effect Analysis of Ambroxol Hydrochloride Combined with Procaterol Hydrochloride in the Treatment of Infantile Pneumonia[J].Journal of Medical Information,2019,32(06):151.[doi:10.3969/j.issn.1006-1959.2019.10.050]
[4]冯瑞丰.阿奇霉素治疗急性细菌性下呼吸道感染的 有效性和安全性评价[J].医学信息,2019,32(11):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
　FENG Rui-feng.Evaluation of the Efficacy and Safety of Azithromycin in the Treatment of Acute Bacterial Lower Respiratory Tract Infections[J].Journal of Medical Information,2019,32(06):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
[5]吴建伟.阿奇霉素联合头孢类药物在慢性阻塞性肺疾病急性加重期抗感染治疗中的疗效[J].医学信息,2022,35(13):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
　WU Jian-wei.Effect of Azithromycin Combined with Cephalosporins in Anti-infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(06):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
[6]陶雪莹,岑 超,何俐莹.盐酸氨溴索联合通窍鼻炎颗粒治疗幼儿分泌性中耳炎的临床效果[J].医学信息,2019,32(20):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
　TAO Xue-ying,CEN Chao,HE Li-ying.Clinical Effect of Ambroxol Hydrochloride Combined with Tongqiao Rhinitis Granules in the Treatment of Secretory Otitis Media in Children[J].Journal of Medical Information,2019,32(06):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
[7]钟红燕.盐酸氨溴索治疗慢阻肺合并肺部感染的临床效果[J].医学信息,2019,32(12):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
　ZHONG Hong-yan.Clinical Effect of Ambroxol Hydrochloride in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Infection[J].Journal of Medical Information,2019,32(06):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
[8]郑婵娟.盐酸氨溴索注射液联合酚妥拉明注射液治疗 小儿重症肺炎的疗效[J].医学信息,2019,32(16):136.[doi:10.3969/j.issn.1006-1959.2019.16.045]
　ZHENG Chan-juan.Efficacy of Ambroxol Hydrochloride Injection Combined with Phentolamine Injection in the Treatment of Severe Pneumonia in Children[J].Journal of Medical Information,2019,32(06):136.[doi:10.3969/j.issn.1006-1959.2019.16.045]
[9]任雨欣.盐酸氨溴索联合二羟丙茶碱对煤工尘肺合并COPD的疗效[J].医学信息,2020,33(03):140.[doi:10.3969/j.issn.1006-1959.2020.03.044]
　REN Yu-xin.Efficacy of Ambroxol Hydrochloride Combined with Dihydroxyprophylline on Coal Workers’ Pneumoconiosis with COPD[J].Journal of Medical Information,2020,33(06):140.[doi:10.3969/j.issn.1006-1959.2020.03.044]
[10]陈艳丽.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性的Meta分析[J].医学信息,2020,33(06):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
　CHEN Yan-li.Meta-analysis of the Efficacy and Safety of Methylprednisolone Combined with Azithromycin in the Treatment of Refractory Mycoplasmal Pneumonia in Children[J].Journal of Medical Information,2020,33(06):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
[11]杨芬香.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎、支气管炎的疗效评价[J].医学信息,2023,36(13):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]
　YANG Fen-xiang.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Pneumonia and Bronchitis in Children[J].Journal of Medical Information,2023,36(06):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]

更新日期/Last Update: 1900-01-01